摘要
目的：探究并分析两组方法治疗幽门螺旋杆菌感染阳性消化性溃疡复发率的前瞻性研究。方法：选取我院自2011年3月-2013年2月收治的幽门螺旋杆菌感染阳性患者64例,将其作为临床研究对象,随机分成治疗组、对照组每组均32例患者。治疗组患者采取奥美拉唑＋阿莫西林＋克拉霉素分散片进行治疗,对照组患者采取奥美拉唑＋阿莫西林＋呋喃唑酮进行治疗,观察两组患者治疗后疗效及不良反应情况。结果：治疗后治疗组与对照组Hp阴转患者分别为18例（56.25%）、13例（40.63%）,P〉0.05无统计学差异,此外出现各种症状患者均无明显差异（P〉0.05）无统计学意义。结论：两组患者分别采取不同药物治疗后,疗效差异较小,不良反应小,对临床治疗有积极作用。
Objective：To discuss and analyze the research on recurrence of the helicobacter pylori infecting peptic ulcer treated with two methods.Methods：64 positive patients infected with helicobacter pylori our hospital received from Mar, 2011-Feb, 2013 were selected and taken as clinical research objets. And they were randomly divided into treatment and control group, each group 32 patients. In treatment group, the patients took omeprazole, amoxicillin and clarithromycin tablets for treatment. While the patients in control group took omeprazole,amoxicillin,and furazolidone for treatment.The the adverse reaction in two groups were observed.Results：After treatment, the Hp positive patients in treatment and control group were 18（56.25%）,13（40.63%） respectively.The result was of no statistical difference with the value of p less than 0.05. Besides, the patients with various symptoms are of no obvious difference（P〉0.05）, without statistical significance.Conclusion：After patients in two groups took different drug treatments, there are small curative differences, light adverse reaction, and conducive to clinical treatment.
出处
《中国医药导刊》
2014年第1期98-98,100,共2页
Chinese Journal of Medicinal Guide
